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Summary 
We have examined the role of endogenously produced interleukin (IL) 4 and IL-10 in the regula- 
tion of inflammatory and immune reactions in the skin. In these experiments, irritant and con- 
tact hypersensitivity (CH) responses were elicited in mice with targeted isruptions of the IL-4 
(IL-4T) or IL-10 (IL-10T) gene. Our study showed that IL-4T and wild-type (wt) mice exhibited 
equivalent responses to the irritant croton oil. In contrast, the response of IL-10T mice challenged 
with croton oil was abnormally increased. When IL-10T mice were exposed to a higher dose 
of irritant, irreversible tissue damage occurred. By comparison, any treatment of wt mice with 
croton oil resulted in far less tissue damage and resolution of inflammation. Neutralizing anti- 
body studies demonstrated that the necrosis ,hat occurred in Ibl0T mice was due to the over- 
production of tumor necrosis factor. The anti-tumor necrosis factor antibody treatment of IL- 
10T mice did not significantly reduce the edema or the influx of inflammatory cells, suggesting 
that these changes were due to the uncontrolled production of other proinflammatory c tokines. 
T cell-dependent immune responses were also evaluated using the contact sensitizer oxazolone. 
The response of IL-4T mice did not differ from wt mice. In contrast, ILol0T mice mounted 
an exaggerated CH response, increased in both magnitude and duration as compared with wt 
mice. Based on these studies, we have concluded that II,-10, but not IL-4, is a natural suppressant 
of irritant responses and of CH, and it limits immunopathologic damage in the skin. 
I L-4 and IL-10 were first identified as products of Th2 clones (1, 2) and are part of the unique cytokine pattern 
that distinguishes Th2 cells from other types of T cells. Th2 
cells are believed to provide major support for the develop- 
ment of humoral immunity. This is due, in part, to the strong 
B cell-stimulating activities of IL-4 and IL-10 (3-6). Numerous 
studies have shown that IL-4 and IL-10 also possess potent 
immunosuppressive activity. IL-4 and IL-10 can inhibit the 
synthesis of proinflammatory c tokines by activated macro- 
phages (7-12). Furthermore, IL-4 and IL-10 can inhibit, directly 
or indirectly, the synthesis of cytokines by Thl clones (12-17). 
Thl cells, in contrast to Th2 cells, produce IFN-~/and TNF-/~ 
and thus have been associated with the generation of cell- 
mediated immunity and delayed-type hypersensitivity reac- 
tions (18). Based on the suppressive actions ascribed to IL-4 
and IL-10 in various in vitro assays, it has been predicted that 
IL-4 and IL-10 may negatively regulate inflammatory and cell- 
mediated responses in vivo. 
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Several investigations have focused on the potential of Ib4 
and II:10 to influence immunological reactions in the skin. 
The possibility that ILo4 and IL-10 are normally involved in 
modifying skin reactions seemed likely, since it was found 
that these proteins can be made by certain cell types that re- 
side in the skin. Recent studies have indicated that, in addi- 
tion to Th2 cells, II,-4 can also be produced by connective 
tissue mast cells (19), which are found in large numbers in 
the skin (20). Production of IL-4 has been documented during 
the sensitization phase of contact hypersensitivity (CH) 1 (21, 
22). Moreover, IL-4 messenger RNA (mRNA) expression 
has been associated with the initiation of acute skin inflam- 
mation in patients with atopic dermatitis (23). IL-10 is pro- 
duced in skin by keratinocytes (24-26) and macrophages (10). 
IL-10 mRNA and protein have been detected in tact skin, 
1 Abbreviations used in this paper: CH, contact hypersensitivity; H & E, he- 
matoxylin and eosin; Ib4T, IL-4 gene with targeted disruption; IL-10T, 
Ibl0 gene with targeted disruption; Ibl0T, Ibl0 gene with targeted dis- 
ruption; mRNA, messenger RNA; TNCB, trinitrochlorobenzene; wt, 
wild type. 
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and their expression is increased after exposure to trinitro- 
chlorobenzene (TNCB) (24, 26) and UV irradiation (27). 
In a model of CH, it was found that IL-10 can regulate 
both the sensitization a d elicitation stages. Injection of mice 
with IL-10 shortly before sensitization with TNCB induced 
anergy (28), and administration f IL-10 before rechallenge 
diminished the recall response (26, 29). In contrast, he infu- 
sion of mice with IL-4 failed to inhibit the sensitization step 
(30). Nevertheless, IL-4 was able to reduce the magnitude 
of the recall response. These results provided evidence that 
exogenous IL-4 and IL-10 may be administered to suppress 
CH reactions. To determine whether IL-4 and IL-10 normally 
function as regulators of CH, neutralizing antibodies were 
given to ablate the activities of endogenously produced pro- 
teins. In mice treated with anti-IL-10 antibodies, the dura- 
tion of the CH response was prolonged (26). In mice treated 
with anti-IL-4 antibodies, there was no effect on the induc- 
tion of CH (21, 30), whereas the effect on the magnitude 
of the response upon rechallenge was variable (21, 30). 
We have evaluated the importance of IL-4 and IL-10 in the 
regulation of inflammatory and immune reactions in skin using 
mice deficient in the production of IL-4 or IL-10. These mu- 
tant mice were generated by targeted isruptions of the IL-4 
(IL-4T; 31) or IL-10 (IL-10T; 32) gene. Gene-targeted animals 
have proven to be valuable models for delineating the activi- 
ties of various cytokines in complex immunologic responses. 
Our study has focused on the role of endogenously produced 
IL-4 and IL-10 to modify two types of skin responses, the 
irritant response and CH. 
Materials and Methods 
Animals. ID10T mice generated on a C57B1/6/129 (B6/129) 
background (32) and wild-type (wt) littermate controls were de- 
rived by cesarean section at Simonsen Laboratory (Gilroy, CA) and 
maintained in our animal facility at DNAX Research Institute (Palo 
Alto, CA). Healthy 5-6-wbold IL-10T mice were used for this 
study. IL-4T mice (31) bred onto the 129J or C57B1/6J background 
were kindly provided by Dr. R. Coffman (DNAX Research Insti- 
tute), wt 129J and C57B1/6J mice were obtained from The Jackson 
Laboratory (Bar Harbor, ME). 
Reagents and Antibodies. Oxazolone ( thoxymethylene-2 phenyl 
oxazolone) and croton oil were obtained from Sigma Chemical Co. 
(St. Louis, MO). Oxazolone was resuspended in 100% EtOH, and 
croton oil was diluted in acetone. Purified rat anti-mouse TNF 
(XT22) and an isotype-matched control mAb, anti-~-galactosidase 
(GL-117), were kindly provided by Dr. J. Abrams (DNAX Research 
Institute). The anti-TNF antibody XT22 was elicited against 
TNP-ce, but it neutralizes both TNF-cr and TNF-B (Abrams, J., 
personal communication). 
Experimental Protocols. The irritant response was induced by 
applying 10/~1 of 1% (vol/vol) croton oil (low dose) or undiluted 
croton oil (high dose) to the dorsal and ventral aspects of the right 
ear. The reaction was evaluated by measuring the increase in ear 
thickness with time. To induce a chronic skin lesion, undiluted 
croton oil (50 #1) was applied to a 1-cm zshaved area on the back 
of wt or IL-10T mice. The resulting inflammatory response was 
monitored by measurement of ulcer formation as well as by micro- 
scopic examination. 
CH was elicited by painting the shaved abdomens ofmice with 
150/zl of a 3% solution of oxazolone. After 6 d, 10 #1 of 1% 
oxazolone was applied to the dorsal and ventral sides of the right 
ear. The reaction was evaluated by measuring ear thickness with 
an engineer's caliper (Mitutoyo/MTI, Paramus, NJ). The amount 
of swelling at 24, 48, 72, and 96 h after challenge was determined 
by measuring the difference in earswelling in challenged (right) 
and unchallenged (left) ears. 
Histologic Analysis. Tissues from utant and normal mice were 
fixed in 10% neutral buffered formalin, routinely processed, sec- 
tioned at 6 #m, and stained with hematoxylin and eosin (H & E). 
Tissue sections were graded semiquantitatively by th  same pathol- 
ogist (M. W. Leach) as 0 (no change) to 4 (most severe). 
Treatment with Anti-TNF Antibodies. Mice were injected in- 
traperitoneally with 2 mg of anti-TNF mAb or anti-~-galactosidase 
mAb 4 h before the application of croton oil. The same lot and 
amount of the anti-TNF mAb used here has been shown toablate 
the effects of endogenously produced TNF in several in vivo models 
(17, 33, 34). 
StatisticalAnalysis. Significant differences between experimental 
groups were valuated by the nonparametric Mann Whitney U test. 
Results 
Irritant Responses of lL,4T and ILIOT Mice Data presented 
in Fig. 1 show the irritant responses of IL-4T and wt mice 
after challenge with the irritant, croton oil. After exposure 
to 1% croton oil, maximal swelling was detected at 24 h, 
with a significant decrease by 48 h (Fig. 1 A). The IL-4T 
mice did not differ from wt in their response to the irritant. 
When the mice were challenged with a higher dose of irri- 
tant, increased swelling was observed at 24 h and maintained 
at 48 h (Fig. 1 B). As with the low-dose treatment, here 
was no difference between Ib4T and wt mice. 
The data presented inFig. 2 show that the irritant responses 
of Ibl0T and wt mice were markedly different. After ex- 
posure to 1% croton oil, the swelling in Ibl0T mice was 
twice that of wt mice (Fig. 2 A). Furthermore, compared 
with the 24-h measurement, the swelling observed in the 
IL-10T ears was only slightly decreased after 48 h, whereas 
the swelling at 48 h in wt mice was diminished by nearly 
50%. To further evaluate the altered irritant responses in IL- 
10T mice, we used croton oil at a higher concentration. We 
found that the swelling in IL-10T mice did not differ signi- 
ficantly from wt mice at 24 h (Fig. 2 B). At 48 h the reaction 
in the wt ears remained high, whereas, unexpectedly, the ears 
of Ibl0T mice showed no evidence of sweUing (Fig. 2 B). 
WT and Ibl0T ears were examined microscopically (Fig. 
3). After challenge with 1% croton oil, wt ears (Fig. 3 C) 
had a predominantly dermal infiltrate of granulocytes and 
mononuclear ceUs, mild edema, and mild hemorrhage. Oc- 
casional intraepidermal pustules were also present. The IL- 
10T ears elicited with 1% croton oil (Fig. 3 D) showed a 
more extensive inflammatory cell infiltrate in the dermis, with 
more edema, moderate hemorrhage, and focal areas of epi- 
thelial necrosis. There was also an increase in the frequency 
and size of intraepidermal pustules. 
Exposure to high-dose croton oil-induced lesions in wt 
ears was consistent with a severe inflammatory response. The 
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Figure 1. Irritant responses of IL-4T mice. The increases in ear thick- 
ness of IL-4T and wt mice on a 129J background (129J) were measured 
24 and 48 h after application of 1% croton oil (low dose; A) and undiluted 
croton oil (high dose; B). Data presented are the mean values _+ SD of 
six mice per group and are representative of two independent experiments. 
Differences between the two groups were not significant, P >0.05. 
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Figure 2. Irritant responses of IL-10T mice. The increases in ear thick- 
ness of ID10T and wt mice on a B6/129 background were measured 24 
and 48 h after application of 1% croton oil (low dose; A) and undiluted 
croton oil (high dose; B). Data presented are the mean values _+ SD of 
six mice per group and are representative of three independent experiments. 
An arrow indicates that no increase in ear thickness was detected. *P <0.01 
compared with values obtained with wt mice at he same time point; t 
P <0.01 compared with wt at 24 h. 
F igure 3. Histologic analysis of the irritant response. Photomicrographs of mouse ears after croton oil treatment (H & E; x180). (A) wt ear, un- 
challenged. (B) Ib l0T  ear, unchallenged. (C) wt ear challenged with 1% croton oil, 24 h. Ear thickening is due to edema and moderate numbers 
of inflammatory cells. There is slight epidermal thickening (open star) secondary to cdlular proliferation (acanthosis). (D) Ib l0T  ear challenged with 
1% croton oil, 24 h. As in the wt, ear thickening is due to edema and infiltration of inflammatory cells. The cartilage is not seen in this field because 
of extensive dema. Epidermal thickening (open star) is secondary to edema rather than cellular proliferation. A large intraepidermal pustule is present 
(upper left, arrow). (E) wt ear challenged with 100% croton oil, 48 h. This is similar to C, but there is more edema, and marked acanthosis (open 
star) is present. (F) IL-10T ear challenged with undiluted croton il, 48 h. The ear is completely necrotic. (G) Ear of wt mouse treated with anti-TNF 
antibody and challenged with 100% croton oil, 48 h. (H) Ear of IL-10T mouse treated with anti-TNF antibody and challenged with 100% croton 
oil, 48 h. Edema and inflammatory cell infiltrate are present, but there is no necrosis. An open star indicates epidermis; a dosed star, dermis; and 
a triangle, cartilage. 
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lesions had a similar appearance at24 and 48 h (a representa- 
tive field at 48 h is shown in Fig. 3 E). Similar lesions were 
also observed in IL-10T ears 24 h after exposure to high-dose 
croton oil. In addition, blood vessels containing fibrin thrombi 
and small areas of hemorrhage were observed in IL-10T ears. 
By 48 h the ears of IL-10T mice had extensive necrosis of 
most of the tissue (Fig. 3 F). The tissue death accounted 
for the absence of measurable swelling at the 48-h time point 
shown in Fig. 2 / i  
Effects of Anti-TNF Antibodies on the Irritant Response to Croton 
Oil. Anti-TNF antibodies were administered to IL-10T and 
wt mice 4 h before challenge with croton oil. Using the low- 
dose protocol, it was found that treating IL-10T mice with 
antibodies did not significantly reduce their ear swelling at 
24 h, although a small reduction was seen at 48 h (Fig. 4 
A). Antibody treatment of wt mice reduced their modest 
ear swelling by >50% at 24 h (Fig. 4 A). 
Using the high-dose protocol, anti-TNF antibodies had 
no effect on the large response elicited in wt and IL-10T mice 
at 24 h, and significant ear swelling was observed (Fig. 4 B). 
Similarly, the anti-TNF treatment had no effect on the sus- 
tained response of wt mice at 48 h. However, anti-TNF was 
found to preserve tissue viability in IL-10T mice, resulting 
in the significant ear swelling detected at 48 h (Fig. 4 B). 
Microscopic examination confirmed the ben ficial effects 
of the anti-TNF treatment. The necrosis observed in the IL- 
10T mice was dramatically reduced (compare Fig. 3, F and 
H), demonstrating the contribution of TNF to the excessive 
tissue damage. The focal necrosis observed in wt mice at the 
high dose was also eliminated. However, the anti-TNF anti- 
body treatment did not prevent edema or the accumulation 
of large numbers of inflammatory cells (Fig. 3, G and H). 
Histopathology of Chronic Lesions Elicited with an Irritant. Be- 
cause the mouse ar is very thin, severe damage licited with 
high-dose croton oil resulted in complete necrosis of the Ib 
10T ears. This event precluded additional studies of the 
pathology associated with chronic inflammation and tissue 
repair. Therefore, a high dose of croton oil was applied to 
the backs of IL-10T and wt mice, as the same (or greater) 
depth of necrosis in this location would cause ulceration yet 
leave an underlying bed of tissue from which repair could 
take place. Several days fter application of croton oil, ulcera- 
tions developed in both the wt and IL-10T mice, but they 
were larger in the IL-10T animals. Microscopic examination 
revealed moderate inflammation, ulceration, and fibrosis in 
the skin of the wt anirr:als (Fig. 5 A). In contrast, he backs 
of the IL-10T mice treated with croton oil showed severe 
inflammation, ecrosis, fibrosis, and serocellular c usting (Fig. 
5 B). While the inflammation i the wt mice involved only 
the skin, IL-10T mice showed extensive inflammation ex- 
tending through the body wall involving muscle and the lining 
of the body cavity (parietal peritoneum). As a result, adhe- 
sions developed between the peritoneum and the liver. 
Contact Hypersensitivity Responses f IL-4T and IL.IOT 
Mice. To further evaluate the role of IL-4 and IL-10 in skin 
responses, we examined the T cell-dependent CH response 
in wt, IL-4T, and IL-10T mice. Data presented in Fig. 6 A 
Figure 4. Effects of anti-TNF antibody treatment on the irritant re- 
sponse. AntbTNF or isotype control mAbs were given to IL-10T and wt 
mice 4 h before application f1% croton oil (A), or undiluted croton 
oil (B). Data presented are mean values _+ SD of six mice per group mea- 
sured at 24 and 48 h after application f the irritant and are representative 
of two independent xperiments. An arrow indicates that no increase in
ear thickness was detected. *P <0.01 compared with values obtained with 
wt mice treated with isotype control antibody. 
show the CH responses of IL-4T mice and wt mice after sen- 
sitization and rechallenge with oxazolone, wt and IL-4T mice 
on a C57B1/6 background gave identical responses to the sen- 
sitizing agent. Similarly, no difference was seen between wt 
and IL-4T mice on a 129/J background, although the mag- 
nitude of the CH response was greater than that observed 
with C57B1/6J mice, demonstrating the contribution of strain 
differences to the CH response. 
In the same type of experiment, the ear swelling of Ibl0T 
(B6/129) mice was found to be greater than that of wt 
(B6/129) mice at 24 h, when the response peaked (Fig. 6 
B). In addition, the response was greatly prolonged in IL- 
10T mice, as swelling was maintained 4 d after challenge. 
Microscopic examination revealed an exaggerated inflamma- 
tory response in the IL-10T mice. As expected, the applica- 
tion of oxazolone to the ears of sensitized wt mice resulted 
in significant edema nd in the accumulation f mononuclear 
cells and neutrophils (Fig. 7 A). In the wt mice, intraepidermal 
pustules containing neutrophils and fewer eosinophils were 
noted on the ear surface. The underlying edematous dermis 
and skeletal muscle tissue contained scattered mixed inflam- 
matory cells, including ranulocytes and mononuclear cells. 
Changes in the ear of IL-10T elicited mice were qualitatively 
similar but were significantly more severe than those seen 
in the wt elicited mice (Fig. 7 B). Epidermal pustules were 
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Figure 5. Histologic analysis of chronic lesions elicited with croton oil. Photomicrographs of lesions 14 d after t eatment of skin with undiluted 
croton oil (H & E; x68). (A) wt lesion showing extensive granulation tissue in the dermis. The overlying epidermis still has ulceration (open star), 
but epidermal cells are present at the edge of the ulcer (arrow). (B) IDIOT lesion, field comparable to A. Granulation tissue is present only in the 
very deep dermis (arrows); all the material bove the arrows is necrotic. No reepithelialization is present. 
larger and more frequent, and in many areas they became 
confluent, sometimes forming seroceUular crusts on the 
surface. 
Discussion 
The skin is a site of significant immunologic activity be- 
cause of its constant exposure to physical trauma, chemical 
irritants, and infectious organisms. A complex set of immune 
reactions has evolved to provide an appropriate defense under 
a variety of circumstances. An integral part of the immune 
response is a mechanism for controlling inflammatory and
immune reactions to prevent immunopathologic damage. We 
have investigated the roles of IL-4 and IL-10 as regulators of 
immune responses in skin by studying the outcome of irri- 
tant responses and CH in IL-4T and IL-10T mice. 
The first type of skin reaction examined was the irritant 
response induced by croton oil. This response is T cell inde- 
pendent and does not require prior sensitization. Instead, the 
mechanism of development depends upon the ability of a 
chemical compound to induce the production of inflamma- 
tory mediators by cells in the skin (35), particularly keratino- 
cytes (36) and Langerhans cells (37). The role of IL-10 in the 
regulation of the irritant response has not been extensively 
studied. In a previous tudy, mRNA for ILIO was not in- 
duced after application of the irritant, sodium lauryl sulfate 
(24). In another study, IL-10 administration did not alter the 
irritant response (29). These reports uggested that the irri- 
tant response was not regulated by IL-10, in contrast to CH. 
However, we have found that the application of croton oil 
to the skin of IL-10T mice produced intense inflammation 
characterized by edema nd leukocyte infiltration. This re- 
sponse was much greater in magnitude and more persistent 
than that observed in similarly treated wtmice, demonstrating 
a clear ole for IL-10 in the regulation of an irritant response. 
The role of IL-4 in the irritant response has not been inves- 
tigated. Our studies howed no alteration i  the irritant re- 
sponse in IL-4T animals. These data suggest that IL-10, but 
not IL-4, functions as a negative regulator of the irritant re- 
sponse in skin. 
104 Contact Hypersensitivity and Irritant Responses in ID4T and IL10T Mice 
50-  A 
6" 
i 
! 
.= 
.r 
! 
4o- T 
30-  
20-  
10 -  
* B 
20-  
t ....... ! i lOq /T I i'-'--"~ 
oI;'3 2 
0 2#, 48 72 96  
Hours post challenge 
Figure 6. CH responses of IL-4T and IL-10T mice. The increases in 
ear thickness of sensitized interleukin-deficient and wt mice were mea- 
sured daily after challenge withoxazolone. Data presented are the mean 
values +_SD of six mice per data point. (/1) Differences between IL-4T 
and wt mice (129J) were not significant, P ;>0.05. Data are representative 
of two independent experiments. Differences betw en IL-4T and wt mice 
(C57B1/6J) were not significant, P ;>0.05. -CF-, wt (129J); - I - ,  ID4T 
(129J); -O--  wt (C57B1/6); - -0 -  IL-4T (C57B1/6). (B) Differences be- 
tween IL-10T and wt mice (B6/129) were significant, *P <0.01. Data are 
representative of three independent experiments. -C~,  wt (B6/129); 
- I - ,  IL-10T (B6/129). 
The importance of IL-10's ability to dampen the irritant 
response was most dearly illustrated by using a higher dose 
of the irritant. When the ears of I1"10T mice were challenged 
with a high dose of croton oil, we found extensive tissue 
necrosis but little evidence of inflammatory cells, suggesting 
that tissue death occurred rapidly and was secondary to ex- 
cessive inflammatory cytokine production by theresident skin 
cells rather than by infiltrating leukocytes. In the case of wt 
mice challenged with the higher dose, the inflammatory e- 
sponse was amplified overall with only scattered areas of 
hemorrhage and epithelial necrosis. These differing outcomes 
demonstrated that I1"10 is essential for modifying inflamma- 
tory reactions to prevent unnecessary tissue damage. 
TNF appears to be the major mediator f cutaneous 
pathology associated with reactions to contact sensitizers and 
irritants (38). Previous studies have shown that intradermal 
injections of TNF-oe into normal mice produced ema, leu- 
kocyte sequestration along the venules, and focal areas of 
necrosis and hemorrhage (38, 39). Conversely, anti-TNF an- 
tibody treatment ofunsensitized and TNCB-sensitized mice 
reduced all of these components upon TNCB challenge (38). 
We found that anti-TNF antibody treatment ofI1-10T mice 
challenged with a high dose of croton oil prevented hemor- 
rhage and tissue necrosis and allowed for the development 
of an inflammatory esponse. These results clearly implicate 
excessive TNF production in the I1"10T mice as the cause 
of necrosis and suggest hat the overproduction f other 
inflammatory mediators (e.g., Ibl, I1"6, chemokines, prosta- 
glandins, leukotrienes, etc.) was the major cause of edema 
and cell recruitment. 
The consequences of an uncontrolled inflammatory response 
became more apparent when we studied the lesions on the 
backs of wt and I1"10T mice painted with croton oil. The 
inflammation elicited in wt mice was limited to the skin, 
and reepithelialization was evident by 2 wk after exposure. 
The inflammatory response in I1"10T mice was much greater, 
involving not only the skin but the entire body wall. Exten- 
sive tissue necrosis ccurred in I1"10T mice, and there was 
minimal evidence of healing. The delay in resolution may 
have been secondary to differences in the size of the lesions 
elicited; however, inhibition of healing cannot be ruled out. 
Previous studies have demonstrated that TNF has an inhibi- 
tory effect on wound healing (40, 41), and hence it is pos- 
sible that excessive production of TNF in IL-10T mice may 
have impaired their ability to heal the wound. 
The second type of skin reaction studied was CH, which 
is a T cell-dependent immune response that requires prior 
sensitization. CH is a complex immunologic phenomenon, 
and there are multiple ways in which it may be regulated 
by IL-10. Results of mRNA studies suggest that proinflamma- 
tory cytokines and chemokines are produced early during the 
initiation phase of CH (36). Keratinocytes and macrophages 
are major sources of these factors, a  well as of I1"10, which 
is known to down-regulate the production of proinflamma- 
tory cytokines (10, 11, 24, 25). Based on evidence provided 
by in vitro (10, 11) as well as in vivo studies (28), it seems 
likely that he absence of11"10 would permit he uncontrolled, 
local production of proinflammatory cytokines, leading to 
an increased r sponse. Other potential sources of proinflamma- 
tory cytokines, as well as II.-10, are activated CD4+ and 
CD8 + T cells (15, 42), which are key participants in CH 
(43-45). Several studies have documented that I1"10 inhibits 
the APC function of macrophages (12-14) andLangerhans 
cells (46) that is required for the activation of cytokine produc- 
tion by CD4 + T cells. Furthermore, II-10 has the potential 
to ablate CH in vivo by inducing anergy in allergen-reactive 
T cells (27, 28). Therefore, I1-10 may modulate the CH re- 
sponse by inhibiting T cell-APC interactions. 
Our data show that I1-10T mice develop an exaggerated 
CH response after sensitization and subsequent challenge wit  
oxazolone. As a result, both the magnitude and duration of 
the response were increased beyond those observed in wt mice. 
Histologic analysis revealed that the responses ofI1-10T and 
wt mice differed quantitatively but not qualitatively. Thus, 
the increased reaction in the ears of I1-10T mice could be 
accounted for by the presence of a larger cellular infiltrate 
and increased edema. In mice depleted of 11-10 by neutralizing 
antibodies (26), the duration, but not he magnitude, ofthe 
CH response was increased. The discrepancy between the 
results obtained with I1"10T mice and with the antibody- 
treated mice may reflect hat, in our study, I1-10 was absent 
during both the sensitization and elicitation phases, whereas 
I1-10 was absent during only the elicitation phase in the an- 
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Figure 7. Histologic analysis of the CH response. (A) wt ear 24 h after challenge with oxazolone. Ear thickening is due to edema nd mild infiltration 
of inflammatory cells (H & E; x 34). (B) IL-10T ear 24h after challenge with oxazolone. The IL-10T ear is thicker than the wt ar because of increased 
edema nd inflammatory cell infiltration. Of ote are the numerous intraepidermal pustules (H & E; x34). (C) Higher magnification of wt ear chal- 
lenged with oxazolone (H & E; x180). Intraepidermal pustules ar  small (arrow). (D) Higher magnification of IL-10T ear challenged with oxazolone 
(H & E; x 180). Intraepidermal pustules (arrow) are larger and more numerous, and they obscure the dermal-epidermal junction. An open star i dicate  
epidermis; a closed star, dermis; and a triangle, cartilage. 
tibody study. The lack of regulation by IL-10 o fT  cell-APC 
interactions during the sensitization phase may have con- 
tributed to the increased magnitude of the CH response seen 
in the IL-10T mice. 
Surprisingly, our studies with IL-4T mice failed to dem- 
onstrate any alteration in their CH response due to the ab- 
sence of ILo4. This was unexpected, considering the previous 
report of IL-4 production in vivo in response to contact sen- 
sitizers, including oxazolone (21, 22). Studies using neu- 
tralizing antibodies to IL-4 have found variable ffects on the 
elicitation phase of CH (21, 30), and in our hands anti-IL-4 
treatment of wt mice at elicitation did not result in an in- 
creased CH response (data not shown). When IL-4T mice 
on either the 129/J or C57B1/6J background were evaluated, 
no differences from wt were detected in the CH response. 
Our study, using two strains of mice deficient in the produc- 
tion of IL-4, has led us to conclude that IL-4 does not regu- 
late the magnitude or duration of the CH response. 
In summary, our data demonstrate hat endogenously pro- 
duced I1,-10, but not IL-4, is an essential regulator of both 
irritant and CH responses in the skin. There is similarity be- 
tween these results and our previous finding that the absence 
of IL-10 resulted in the development of an exaggerated inflam- 
matory response in the gastrointestinal tract (32). Both the 
skin and the gastrointestinal tract are exposed to large numbers 
of potential antigens and irritants. The immune response must 
be carefully balanced so that a proper defense is mounted 
without causing excessive immunopathologic damage. Our 
studies indicate that the role of IL-10, i.e., to prevent prolonged 
and exaggerated immune/inflammatory responses to antigens 
and irritants, is similar in both the skin and the gastrointes- 
tinal tract. 
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